Showing results (71-80 of 3,079) with videos related to
Sort By:
Pageof 308
Drug Safety|November 24, 2004
Fab antibody fragments: some applications in clinical toxicologyRobert J Flanagan, Alison L JonesDrug Safety|November 24, 2004
Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescentsPaz Toren, Sharon Ratner, Nathaniel Laor, et al.Drug Safety|February 5, 2005
Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable diseaseMark Bigham, Ray CopesDrug Safety|February 5, 2005
Immunotoxicology: role in the safety assessment of drugsJacques DescotesDrug Safety|January 14, 2004
A benefit-risk assessment of basiliximab in renal transplantationUgo Boggi, Romano Danesi, Fabio Vistoli, et al.Drug Safety|January 14, 2004
Comparative tolerability of sedative agents in head-injured adultsSusan C Urwin, David K MenonDrug Safety|January 15, 2004
Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerationsMiriam Romero, Mayte Pérez-Olmeda, Javier García-Samaniego, et al.Drug Safety|January 15, 2004
Failure to continue lipid-lowering drug use following the withdrawal of cerivastatinAukje K Mantel-Teeuwisse, Olaf H Klungel, Toine C G Egberts, et al.Drug Safety|January 1, 1992
On the possible mechanisms and predictability of clozapine-induced agranulocytosisA V Pisciotta, S A Konings, L L Ciesemier, et al.Pageof 308